The Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute at University Hospitals in Cleveland have granted an ADDF-Harrington Scholar Award to Christiane Wrann, PhD, DVM, Associate Professor in Medicine at the Cardiovascular Research Center and the McCance Center for Brain Health at Massachusetts General Hospital and the Harvard Medical School in Boston. Dr. Wrann will receive funding and drug development guidance to help advance her research towards potential new therapies for patients suffering from Alzheimer’s disease.
Announcement of the addition of Goutham Rao, MD, FAHA, to the U.S. Preventive Services Task Force (Task Force) to serve a four-year term, beginning this month. Dr. Rao will join fellow experts from primary care and prevention-related fields to rigorously review evidence and evaluate the benefits and harms of preventive services. The Agency for Healthcare Research and Quality (AHRQ) convenes the Task Force and provides scientific, administrative, and dissemination support.
Health article about how the holidays can add stress to your life, and left unchecked, the stress and anxiety can be detrimental to physical and mental health, including heart health.
University Hospitals (UH) today announced the completion of the first arthroscopic surgeries in Ohio, and amongst the first ever, using the new ArthroFree® Wireless Camera System. ArthroFree is the first wireless surgical camera system to receive market clearance from the U.S. Food and Drug Administration for use in broad endoscopic applications including arthroscopy.
University Hospitals (UH) is a leader in the national healthcare transformation focusing on providing proactive well-care that is as robust as the reactive sick-care system of treating disease. This approach to well-being is at the root of a new continuing education opportunity now being offered to all UH caregivers.
Announcement of a gift to University Hospitals Samaritan Medical Center, in Ashland, Ohio, from the Samaritan Hospital Foundation. The foundation has awarded an unprecedented $10 million grant. The gift supplements the Foundation’s annual support of the hospital which averages $2 million each year and promises to impact patient care and services for decades to come.
After statins, the next leading class of medications for managing cholesterol are PCSK9 inhibitors. These highly effective agents help the body pull excess cholesterol from the blood, but unlike statins, which are available as oral agents, PCSK9 inhibitors can only be administered as shots, creating barriers to their use.
In its most recent Community Benefit Report covering 2021, University Hospitals (UH) showcases recent examples of its continued effort to address health and economic disparities in Cleveland and Northeast Ohio. Over the past 10 years, UH has invested $3.5 billion in community benefit expenditures, and in 2021 alone, the health system’s community benefit expenditures totaled $531 million.
New research published in the Journal of the American College of Cardiology shows the use of drug-coated balloons is an optimal approach compared to bare metal stents in treating femoropopliteal lesions.
Thousands of people have new hope for treatment of thoracic aortic arch disease and UH Harrington Heart & Vascular Institute is at the forefront of studying the safety and efficacy of this new procedure.
Researchers at University Hospitals (UH) Seidman Cancer Center in Cleveland, Ohio and a biotech start-up company have developed a streamlined way to manufacture CAR T-cells for immunotherapy treatment in just 24 hours – an improvement over the team’s previous benchmark of eight days and commercial suppliers that typically take three weeks. The team is one of the first in the country to test this manufacturing approach.
Announcement that the Design Management Institute (dmi) recognized University Hospitals Cutler Center for Men as the second-place recipient of its 2022 dmi Design Value Awards on Sept. 27, and the Service Design Network (SDN) named the center a finalist for the 2022 Service Design Network Award in the Professional Non-Profit/Public Sector category on Oct. 13.
A team at University Hospitals in Cleveland aims to unearth potential immunologic mechanisms and understanding of COVID-19 upon long-term consequences and outcomes thanks to a grant from the American Lung Association.
University Hospitals in Cleveland has received national recognition for its care of patients with uncontrolled blood pressure, diabetes, heart disease, and stroke.
Announcement of transformational support from Cleveland community leaders Michael and Grace Drusinsky will benefit advanced orthopedic and sports medicine care at University Hospitals. In recognition, the system has renamed its nationally recognized sports medicine program in their honor: UH Drusinsky Sports Medicine Institute.
A nanoparticle therapy developed by investigators at University Hospitals (UH) and Case Western Reserve University targets overactive neutrophils, a specific kind of white blood cell, to prevent almost all types of blood clots while causing no increased risk for bleeding. The preclinical findings, published in Science Translational Medicine, may lead to safer ways to care for patients impacted by blood clots. According to the Centers for Disease Control and Prevention (CDC), roughly 900,000 people in the U.S. suffer from life-threatening blood clots each year.
UH Harrington Heart & Vascular Institute has a rich history of providing the highest level of care for patients. Continuing as leaders in this field and elevating cardiac surgery patient care to a new level, UH announces the addition of Rakesh Arora, MD, PhD, FRCSC, FACS, a world leader in perioperative care and management of cardiac surgery patients.